• Nie Znaleziono Wyników

Intraductal pancreatic stent fragmentation in patients with walled-off pancreatic necrosis and pancreatic duct disruption

N/A
N/A
Protected

Academic year: 2022

Share "Intraductal pancreatic stent fragmentation in patients with walled-off pancreatic necrosis and pancreatic duct disruption"

Copied!
3
0
0

Pełen tekst

(1)

Gastroenterology Review 2018; 13 (2)

Short communication

Intraductal pancreatic stent fragmentation in patients with walled-off pancreatic necrosis and pancreatic duct disruption

Mateusz Jagielski, Marian Smoczyński, Krystian Adrych

Department of Gastroenterology and Hepatology, Medical University of Gdansk, Gdansk, Poland

Gastroenterology Rev 2018; 13 (2): 157–159 DOI: https://doi.org/10.5114/pg.2018.75279

Address for correspondence: Mateusz Jagielski MD, PhD, Department of Gastroenterology and Hepatology, Medical University of Gdansk, 17 Smoluchowskiego St, 80-214 Gdansk, Poland, phone: +48 78 114 36 96, e-mail: matjagiel@gmail.com

We published our article in the November-December 2017 issue of “Digestive Endoscopy” [1]. In it we pre- sented the results of treatment of a rare complication of pancreatic endotherapy in the form of intraductal stent fragmentation in 33 patients with chronic pancreatitis [1]. We demonstrated that most of the broken pancre- atic stent fragments can be removed endoscopically from the pancreatic duct with an acceptable complica- tion rate [1]. Furthermore, intraductal pancreatic stent fragmentation was discovered significantly more often in patients with chronic calcific pancreatitis and in pa- tients with pancreatic stones inside the main pancreatic duct [1]. Nevertheless, we would like to focus attention on the 4/33 (12.12%) patients from our study who had a diagnosis of non-calcific type of chronic pancreatitis (Figure 1) [1]. Pancreatic duct disruption was an indica- tion for endotherapy in each of the 4 patients [1]. We find it difficult to explain the possible cause of pancre- atic stent fragmentation in this group.

Recently in our medical center we completed a ret- rospective analysis of 451 procedures of endoscopic retrograde pancreatography (ERP) with stenting of the main pancreatic duct. The procedures were carried out between 2001 and 2016 in 166 patients (122 men, 44 women, mean age: 52.96 ±13.27; range: 26–86) with walled-off pancreatic necrosis and pancreatic duct dis- ruption. What is interesting, intraductal pancreatic stent fragmentation was recognized during 2/451 (0.44%) endoscopic procedures in 2/166 (1.2%) patients only (Figure 2). In these 2 patients the fragments of broken pancreatic stents were removed with rat tooth forceps.

The mentioned outcomes confirm that intraductal pancreatic stent fragmentation is in fact an extreme- ly rare complication of pancreatic endotherapy. In this short article we aim to be sensitive to the fact that

a broken pancreatic stent may also occur in patients undergoing endoscopic treatment of main pancreatic duct disruption, regardless of the diagnosis of chron- ic pancreatitis. We agree with the majority of authors [2–4] that endoscopic procedures should be attempted at centers experienced in retrieval of broken pancreatic stents, despite the lack of guidelines for treatment of intraductal pancreatic stent fragmentation. We have developed in our medical center the strategy of endo- scopic treatment of intraductal pancreatic stent frag- mentation [1], which we also use in the patients with a proximally migrated pancreatic stent. According to our

Figure 1. A 62-year-old patient with non-calcific chronic pancreatitis. The pancreatic broken stent in the pancreatic duct that was retrieved with rat tooth forceps

(2)

158 Mateusz Jagielski, Marian Smoczyński, Krystian Adrych

Gastroenterology Review 2018; 13 (2)

strategy, the first instrument used for retrieval of parts of the broken stent during each endoscopic procedure was rat-tooth grasping forceps (Figure 1). Retrieval of a broken pancreatic stent with forceps is a better meth- od than removal using a basket or snare, because it allows the fragment’s proximal tip to be grasped and the procedure is then less traumatic. Previous dilation of the main pancreatic duct with a high-pressure bal- loon enabled opening of the forceps (Figure 2), catch- ing the broken stent fragment and its retrieval. Other instruments were used during the same endoscopic procedure only after a few unsuccessful attempts of removal of stent fragments from the lumen of the main

pancreatic duct with forceps. However, in some cases it is necessary to use a polypectomy snare or Dormia basket, especially when the fragment of a broken stent is positioned in the pancreatic tail.

Another problem is the fact that patients with this type of complication are usually asymptomatic. In our opinion, an attempt of endoscopic removal of the mi- grated or broken pancreatic stent should be made prior to the considered surgical intervention, regardless of the lack of symptoms.

Conflict of interest

The authors declare no conflict of interest.

Figure 2. A 60-year-old man with intraductal pancreatic stent fragmentation during endoscopic treatment of pancreatic duct disruption and walled-off pancreatic necrosis as consequences of acute necrotizing pancre- atitis. The fragments of broken stent were removed with forceps after dilation with a high pressure balloon

A B

D

C

(3)

Intraductal pancreatic stent fragmentation in patients with walled-off pancreatic necrosis and pancreatic duct disruption 159

Gastroenterology Review 2018; 13 (2) References

1. Jagielski M, Smoczyński M, Jabłońska A, Adrych K. Endoscopic treatment of intraductal pancreatic stent fragmentation. Dig Endosc 2017; 29: 798-805.

2. Johanson JF, Schmalz MJ, Geenen JE. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc 1992; 38: 341 6.

3. Kawaguchi Y, Lin JC, Kawashima Y, et al. Risk factors for migra- tion, fracture, and dislocation of pancreatic stents. Gastroen- terol Res Pract 2015; 2015: 365457.

4. Matsumoto K, Katanuma A, Maguchi H. Endoscopic removal technique of migrated pancreatic plastic stents. J Hepatobiliary Pancreat Sci 2014; 21: E34-40.

Received: 29.01.2018 Accepted: 21.03.2018

Cytaty

Powiązane dokumenty

Assessment I – 100% strong acceptance, data reliability C Primary surgical resection of the primary tumour and regional lymph nodes is recommended for patients with

Transmural endoscopic drainage in our study might have been a key to success in preven- tion of creation of pancreatic fistulas in patients with WOPN, who were treated with

In numerous publications it has been proved that application of endoscopic ultrasonography (EUS) in transmural drainage of pancreatic fluid collections (PFCs) increases

[34] published the results of a randomised trial PENGUIN (Pancreatitis, ENdoscopic transGastric versUs primary necrosectomy in patients with Infected Necrosis), which

Regardless of whether diabetes is a risk factor or a symptom of pancreatic tumours, it seems that there is an inseparable relationship, and in order to increase the percentage

When analysing plasma Cu/Zn-SOD and total peroxides in relation to disease staging, we found a tendency to greater peroxide levels in advanced pancreatic cancer patients (with

Europejski Klub Trzustkowy (European Pancreatic Club, EPC) jest stowarzyszeniem założonym podczas sym- pozjum dotyczącego chorób trzustki, odbywającego się w Londynie w dniach

Czas prze¿ycia pacjentów po opera- cjach odbarczaj¹cych wynosi³ od 8 do 14 tyg., zaœ chorych nie kwalifi- kuj¹cych siê do innych procedur ni¿.. laparotomia wynosi³ œrednio